Trial · NCT07895745
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Local Control (LC) | From randomization until local failure or last follow-up (up to 2 years) | Local control (LC), defined as the time from randomization to the date of local failure, after comprehensive clinical examination and radiographic evaluation. |
| Secondary | Locoregional Failure (LRF) | 2 Years | |
| Secondary | Distant Metastasis (DM) | 2 Years | |
| Secondary | Laryngectomy free survival (LFS) | 2 Years | |
| Secondary | Disease free survival (DFS) | 2 Years | |
| Secondary | Overall survival (OS) | 2 Years | Overall survival (OS) is defined as the time from the date of randomization to the date of death due to any cause. |
| Secondary | Physician-assessed toxicities | 2 Years | National Cancer Institute (NCI) Common Terminology Criteria of Adverse Events (CTCAE) V.6, where higher grades indicate greater severity of toxicity. |
| Secondary | Patient-reported toxicities | 2 Years | Patient Reported Outcomes - Common Terminology Criteria of Adverse Events (PRO CTCAE) V.1, where higher scores indicate greater symptom burden and worse patient-reported toxicity. |
| Secondary | Quality of life (QOL) (UW-QOL) | 2 years | Head and Neck Cancer Specific QOL \[University of Washington Quality of Life Questionnaire (UW-QOL)\], where higher scores indicate a better quality of life. |
| Secondary | Quality of life (QOL): Voice Handicap Index (VHI) | 2 Years | Voice Handicap Index (VHI): a patient-reported questionnaire that assesses the functional, physical, and emotional impact of voice disorders, where higher scores indicate greater voice-related handicap. |
| Secondary | Quality of life (QOL): Swallowing-related quality of life [M.D. Anderson Dysphagia Inventory (MDADI)] | 2 Years | Swallowing-related quality of life \[M.D. Anderson Dysphagia Inventory (MDADI)\]: a patient-reported questionnaire assessing the impact of dysphagia on quality of life. Higher scores indicate better swallowing-related quality of life. |
| Secondary | Financial Toxicity | 2 Years | Financial Index of Toxicity (FIT)\]: assesses the financial burden and impact of cancer treatment on patients. Higher scores indicate greater financial toxicity |
| Secondary | Health Economics (EQ-5D-5L) | 2 Years | Cost-utility analysis using health utilization costs and health utility instruments (EQ-5D-5L), including lost productivity. Higher scores indicate better health-related quality of life. |
| Secondary | Health Economics (HNC-8D) | 2 Years | Cost-utility analysis using health utilization costs and health utility instruments (HNC-8D), including lost productivity. Higher scores indicate better health status. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07895745/registered